Clinical Trials Directory

Trials / Unknown

UnknownNCT04111653

Exploration of the Transfer of Barium From Thermal Mud

Exploration of the Transfer of Barium From Thermal Mud (T2BT Study)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Association Francaise pour la Recherche Thermale · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

It involves conducting a clinical study on a population of healthy volunteers (age between 18 and 30 years) without direct benefit for the subject to explore a transfer of barium in the blood and urine following applications of thermal mud. The main objective is to highlight an increase in serum barium level of at least twice.

Detailed description

The presence of barium in thermal clays was noted by the ARS (french administration) who interviewed the Directorate General of Health (DGS); the latter seized the National Academy of Medicine (June 2016) which reported in February 2017. In this report it was stated that there was no argument in favor of toxic phenomena related to the presence of barium but that it was appropriate, in particular, to evaluate a possible passage of barium in the skin in subjects who are treated with thermal mud * by observing, where appropriate, an increase in serum and urinary barium levels in the subjects concerned and * by measuring a possible depletion of barium in the sludge used. The DGS validated the various recommendations of the Academy and asked, in January 2018, the National Council of Thermal Establishments (CNETH) to implement the recommendations of the Academy. It will therefore be a prospective before-after interventional study, implementing 15 daily applications of 6 mud poultices made with a clay used as thermal clay and containing appreciable barium levels. A surveillance will be put in place with the event of suspected event, the volunteer can then be seen by a doctor.

Conditions

Interventions

TypeNameDescription
OTHERMud therapyApplication of sludge poultice

Timeline

Start date
2020-01-13
Primary completion
2020-07-30
Completion
2020-09-30
First posted
2019-10-01
Last updated
2020-07-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04111653. Inclusion in this directory is not an endorsement.